CRABP2 and ovarian carcinoma: Finally, we identify that CRABP2 is upregulated in ovarian cancer tissues and can be detected at a higher level in the exosome of patients, which might serve as a biomarker and surmount the obstacles in the early diagnosis and targeted therapy of ovarian carcinoma.